Neurodegenerative Diseases Flashcards
Parkinsons involves which two main brainregions
SN
VTA
When dopaminergic neurons that stretch from the substantia nigra to the corpus striatum begin to deteriorate, what happens
the dopamine neurons extending from sub nigra keep a balance between Ach neurons and GABA neurons in the Corpus striatum. When we lose the dopamine neurons, Ach neurons takes over the GABA neurons which causes involuntary movements. It has been thought that we can block cholinergic transmission to regain function.
Dopamine cant cross BBB but L dopa can the diff is that L dopa has an additional carboxyl group which can be taken up by amino acid transporter to get into CNS. In brain it gets cut to form dopamine. What is the problem here?
l-dopa gets cut in periphery and can cause problems .. caribdopa blocks this in the periphery and carbidopa cannot cross BBB. Carbidopa inhibits decarboxylase.
Lines of treatment in parkinsons
increase L dopa
dopamine receptor agonist to mimick dopamine effect
Influence metabolism of dopamine and prevent its breakdown
Dopamine agonist (4)
Bromocriptine
Pergolide
Pramipexole
Ropinrole
MAO-B does what
breaks down dopamine
COMT does what
breaks down dopamine
MAO-B inhibitors
Selegilline, rasagilline
COMT inhibitor
Tolcapone and Entacapone
Drugs targeting MAO-A is used to treat
depression
MAO-A is involved in the metabolism of
norepi
MAO-B is involved in the metabolism of
dopamine
Patients may have drug induced Parkinson’s because there are drugs that block D2 receptors in dopaminergic transmission these drug classes are
neuroleptics and antipsychotics . These drugs inhibit dopamine transmission.
Ach blocking drugs
Benzotropine
Biperiden
Procyclidine
Benzotropine
Biperiden
Procyclidine All these drugs target what
Muscarinic recpeptors. They partially block nicotinic but mostly muscarinic
These have lots of side effects becasue they block Ach on the periphery. I,e (saliva) Results from nonspecific binding causing anti cholinergic effects.
Amantadine
anti viral drug— been shown to inhibit NMDA receptors which can help manage Parkinson’s.
Apomorphine
injected. Increases dopaminergic D2 receptors . Usually used in patients who are experiecning bad problems with Parkinson’s. This drug is highly emetogenic.
This was used to target ameloid plaques but patients were still dementing
Humanized mono-clonal antibodies.